The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine

Jason L Vassy, Denise M Lautenbach, Heather M McLaughlin, Sek Won Kong, Kurt D Christensen, Joel Krier, Isaac S Kohane, Lindsay Z Feuerman, Jennifer Blumenthal-Barby, J Scott Roberts, Lisa Soleymani Lehmann, Carolyn Y Ho, Peter A Ubel, Calum A MacRae, Christine E Seidman, Michael F Murray, Amy L McGuire, Heidi L Rehm, Robert C Green, MedSeq Project, David W Bates, Alexis D Carere, Allison Cirino, Lauren Connor, Kurt D Christensen, Jake Duggan, Robert C Green, Carolyn Y Ho, Joel B Krier, William J Lane, Denise M Lautenbach, Lisa Lehmann, Christina Liu, Calum A MacRae, Rachel Miller, Cynthia C Morton, Christine E Seidman, Shamil Sunyaev, Jason L Vassy, Sandy Aronson, Ozge Ceyhan-Birsoy, Siva Gowrisankar, Matthew S Lebo, Ignat Leschiner, Kalotina Machini, Heather M McLaughlin, Danielle R Metterville, Heidi L Rehm, Jennifer Blumenthal-Barby, Lindsay Zausmer Feuerman, Amy L McGuire, Sarita Panchang, Jill Oliver Robinson, Melody J Slashinski, Stewart C Alexander, Kelly Davis, Peter A Ubel, Peter Kraft, J Scott Roberts, Judy E Garber, Tina Hambuch, Michael F Murray, Isaac S Kohane, Sek Won Kong, In-Hee Lee, Jason L Vassy, Denise M Lautenbach, Heather M McLaughlin, Sek Won Kong, Kurt D Christensen, Joel Krier, Isaac S Kohane, Lindsay Z Feuerman, Jennifer Blumenthal-Barby, J Scott Roberts, Lisa Soleymani Lehmann, Carolyn Y Ho, Peter A Ubel, Calum A MacRae, Christine E Seidman, Michael F Murray, Amy L McGuire, Heidi L Rehm, Robert C Green, MedSeq Project, David W Bates, Alexis D Carere, Allison Cirino, Lauren Connor, Kurt D Christensen, Jake Duggan, Robert C Green, Carolyn Y Ho, Joel B Krier, William J Lane, Denise M Lautenbach, Lisa Lehmann, Christina Liu, Calum A MacRae, Rachel Miller, Cynthia C Morton, Christine E Seidman, Shamil Sunyaev, Jason L Vassy, Sandy Aronson, Ozge Ceyhan-Birsoy, Siva Gowrisankar, Matthew S Lebo, Ignat Leschiner, Kalotina Machini, Heather M McLaughlin, Danielle R Metterville, Heidi L Rehm, Jennifer Blumenthal-Barby, Lindsay Zausmer Feuerman, Amy L McGuire, Sarita Panchang, Jill Oliver Robinson, Melody J Slashinski, Stewart C Alexander, Kelly Davis, Peter A Ubel, Peter Kraft, J Scott Roberts, Judy E Garber, Tina Hambuch, Michael F Murray, Isaac S Kohane, Sek Won Kong, In-Hee Lee

Abstract

Background: Whole genome sequencing (WGS) is already being used in certain clinical and research settings, but its impact on patient well-being, health-care utilization, and clinical decision-making remains largely unstudied. It is also unknown how best to communicate sequencing results to physicians and patients to improve health. We describe the design of the MedSeq Project: the first randomized trials of WGS in clinical care.

Methods/design: This pair of randomized controlled trials compares WGS to standard of care in two clinical contexts: (a) disease-specific genomic medicine in a cardiomyopathy clinic and (b) general genomic medicine in primary care. We are recruiting 8 to 12 cardiologists, 8 to 12 primary care physicians, and approximately 200 of their patients. Patient participants in both the cardiology and primary care trials are randomly assigned to receive a family history assessment with or without WGS. Our laboratory delivers a genome report to physician participants that balances the needs to enhance understandability of genomic information and to convey its complexity. We provide an educational curriculum for physician participants and offer them a hotline to genetics professionals for guidance in interpreting and managing their patients' genome reports. Using varied data sources, including surveys, semi-structured interviews, and review of clinical data, we measure the attitudes, behaviors and outcomes of physician and patient participants at multiple time points before and after the disclosure of these results.

Discussion: The impact of emerging sequencing technologies on patient care is unclear. We have designed a process of interpreting WGS results and delivering them to physicians in a way that anticipates how we envision genomic medicine will evolve in the near future. That is, our WGS report provides clinically relevant information while communicating the complexity and uncertainty of WGS results to physicians and, through physicians, to their patients. This project will not only illuminate the impact of integrating genomic medicine into the clinical care of patients but also inform the design of future studies.

Trial registration: ClinicalTrials.gov identifier NCT01736566.

Figures

Figure 1
Figure 1
MedSeq project study schema. DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy.

References

    1. The Human Genome Project Completion: Frequently Asked Questions. [ ]
    1. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL, Basehore MJ, Broeckel U, Tomita-Mitchell A, Arca MJ, Casper JT, Margolis DA, Bick DP, Hessner MJ, Routes JM, Verbsky JW, Jacob HJ, Dimmock DP. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255–262. doi: 10.1097/GIM.0b013e3182088158.
    1. Knies K, Schuster B, Ameziane N, Rooimans M, Bettecken T, de Winter J, Schindler D. Genotyping of Fanconi anemia patients by whole exome sequencing: advantages and challenges. PLoS One. 2012;7:e52648. doi: 10.1371/journal.pone.0052648.
    1. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I, Reid JG, Fink JK, Morgan MB, Gingras MC, Muzny DM, Hoang LD, Yousaf S, Lupski JR, Gibbs RA. Whole-genome sequencing for optimized patient management. Sci Transl Med. 2011;3:87re83.
    1. Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S, Middha S, Asmann Y, Schmidt J, Braggio E, Keats JJ, Fonseca R, Bergsagel PL, Craig DW, Carpten JD, Stewart AK. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 2012;120:1060–1066. doi: 10.1182/blood-2012-01-405977.
    1. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4:154ra135.
    1. Talkowski ME, Ordulu Z, Pillalamarri V, Benson CB, Blumenthal I, Connolly S, Hanscom C, Hussain N, Pereira S, Picker J, Rosenfeld JA, Shaffer LG, Wilkins-Haug LE, Gusella JF, Morton CC. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med. 2012;367:2226–2232. doi: 10.1056/NEJMoa1208594.
    1. Altman RB. Personal genomic measurements: the opportunity for information integration. Clin Pharmacol Ther. 2013;93:21–23. doi: 10.1038/clpt.2012.203.
    1. Green RC, Rehm HL, Kohane IS. Genomic and Personalized Medicine. Vol. 1. 2. Waltham, PA: Academic Press; 2013. Clinical genome sequencing; pp. 102–122.
    1. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, Braxton A, Beuten J, Xia F, Niu Z, Hardison M, Person R, Bekheirnia MR, Leduc MS, Kirby A, Pham P, Scull J, Wang M, Ding Y, Plon SE, Lupski JR, Beaudet AL, Gibbs RA, Eng CM. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–1511. doi: 10.1056/NEJMoa1306555.
    1. Catalog of Published Genome-Wide Association Studies. [ ]
    1. Goldberger JJ, Buxton AE. Personalized medicine vs guideline-based medicine. JAMA. 2013;309:2559–2560. doi: 10.1001/jama.2013.6629.
    1. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers’ attitudes toward direct-to-consumer personal genome testing. Am J Bioeth. 2009;9:3–10.
    1. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA. 2006;296:212–215. doi: 10.1001/jama.296.2.212.
    1. McGuire AL, Burke W. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA. 2008;300:2669–2671. doi: 10.1001/jama.2008.803.
    1. Green E, Guyer M. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470:204–213. doi: 10.1038/nature09764.
    1. Khoury MJ, McCabe LL, McCabe RB. Population screening in the age of genomic medicine. N Engl J Med. 2003;348:50–58. doi: 10.1056/NEJMra013182.
    1. Khoury M, Berg A, Coates R, Evans J, Teutsch S, Bradley L. The evidence dilemma in genomic medicine. Health Aff. 2008;27:1600–1611. doi: 10.1377/hlthaff.27.6.1600.
    1. Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368:1199–1209. doi: 10.1056/NEJMoa1213261.
    1. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA, McGuire AL, Zhang F, Stankiewicz P, Halperin JJ, Yang C, Gehman C, Guo D, Irikat RK, Tom W, Fantin NJ, Muzny DM, Gibbs RA. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med. 2010;362:1181–1191. doi: 10.1056/NEJMoa0908094.
    1. Maxmen A. Exome sequencing deciphers rare diseases. Cell. 2011;144:635–637. doi: 10.1016/j.cell.2011.02.033.
    1. Quaynor SD, Stradtman EW Jr, Kim HG, Shen Y, Chorich LP, Schreihofer DA, Layman LC. Delayed puberty and estrogen resistance in a woman with estrogen receptor alpha variant. N Engl J Med. 2013;369:164–171. doi: 10.1056/NEJMoa1303611.
    1. Koser CU, Bryant JM, Becq J, Torok ME, Ellington MJ, Marti-Renom MA, Carmichael AJ, Parkhill J, Smith GP, Peacock SJ. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med. 2013;369:290–292. doi: 10.1056/NEJMc1215305.
    1. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M, Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR, Schulz-Trieglaff OB, Smith GP, Peacock SJ. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med. 2012;366:2267–2275. doi: 10.1056/NEJMoa1109910.
    1. Loman NJ, Constantinidou C, Christner M, Rohde H, Chan JZ, Quick J, Weir JC, Quince C, Smith GP, Betley JR, Aepfelbacher M, Pallen MJ. A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of shiga-toxigenic escherichia coli O104:H4. JAMA. 2013;309:1502–1510. doi: 10.1001/jama.2013.3231.
    1. Crotti L, Tester DJ, White WM, Bartos DC, Insolia R, Besana A, Kunic JD, Will ML, Velasco EJ, Bair JJ, Ghidoni A, Cetin I, Van Dyke DL, Wick MJ, Brost B, Delisle BP, Facchinetti F, George AL, Schwartz PJ, Ackerman MJ. Long QT syndrome-associated mutations in intrauterine fetal death. JAMA. 2013;309:1473–1482. doi: 10.1001/jama.2013.3219.
    1. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–574. doi: 10.1038/gim.2013.73.
    1. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, Kim JH, Rosenthal EA, Kim DS, Tabor HK, Bamshad MJ, Motulsky AG, Scott CR, Pritchard CC, Walsh T, Burke W, Raskind WH, Byers P, Hisama FM, Nickerson DA, Jarvik GP. National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project. Actionable, pathogenic incidental findings in 1,000 participants’ exomes. Am J Hum Genet. 2013;93:631–640. doi: 10.1016/j.ajhg.2013.08.006.
    1. Laboratory for Molecular Medicine variant classification rules. [ ]
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. My Family Health Portrait: A Tool from the Surgeon General. [ ]
    1. Nippert I, Harris HJ, Julian-Reynier C, Kristoffersson U, Ten Kate LP, Anionwu E, Benjamin C, Challen K, Schmidtke J, Nippert RP, Harris R. Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-Part 1. J Community Genet. 2011;2:1–11. doi: 10.1007/s12687-010-0030-0.
    1. Najafzadeh M, Lynd LD, Davis JC, Bryan S, Anis A, Marra M, Marra CA. Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment. Genet Med. 2012;14:520–526. doi: 10.1038/gim.2011.26.
    1. Selkirk CG, Weissman SM, Anderson A, Hulick PJ. Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. Genet Test Mol Biomarkers. 2013;17:219–225. doi: 10.1089/gtmb.2012.0165.
    1. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299:1320–1334. doi: 10.1001/jama.299.11.1320.
    1. Korf BR, Ledbetter D, Murray MF. Report of the banbury summit meeting on the evolving role of the medical geneticist, February 12–14, 2006. Genet Med. 2008;10:502–507. doi: 10.1097/GIM.0b013e31817701fe.
    1. Cooksey JA, Forte G, Benkendorf J, Blitzer MG. The state of the medical geneticist workforce: findings of the 2003 survey of American Board of Medical Genetics certified geneticists. Genet Med. 2005;7:439–443. doi: 10.1097/01.GIM.0000172416.35285.9F.
    1. Association of American Medical Colleges Center for Workforce Studies. Recent Studies and Reports on Physician Shortages in the US. Washington, DC: Association of American Medical Colleges Center for Workforce Studies; 2012.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J, Carter RJ, Keira Cheetham R, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray SJ, Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ, Obradovic B, Ost T, Parkinson ML, Pratt MR, Rasolonjatovo IM, Reed MT. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456:53–59. doi: 10.1038/nature07517.
    1. Cooper DN, Stenson PD, Chuzhanova NA. The human gene mutation database (HGMD) and its exploitation in the study of mutational mechanisms. Curr Protoc Bioinformatics. 2006;Chapter 1:Unit 1 13.
    1. NHLBI Exome Sequencing Project (ESP): Exome Variant Server. [ ]
    1. Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly M, Pugh T, Funke B, Rehm H, Lebo M. A systematic approach to assessing the clinical significance of genetic variants. Clin Genet. 2013;84:453–463. doi: 10.1111/cge.12257.
    1. Via M, Gignoux C, Burchard E. The 1000 genomes project: new opportunities for research and social challenges. Genome Med. 2010;2:3. doi: 10.1186/gm124.
    1. Aronson SJ, Clark EH, Babb LJ, Baxter S, Farwell LM, Funke BH, Hernandez AL, Joshi VA, Lyon E, Parthum AR, Russell FJ, Varugheese M, Venman TC, Rehm HL. The GeneInsight suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat. 2011;32:532–536. doi: 10.1002/humu.21470.
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295–309. doi: 10.7326/0003-4819-148-4-200802190-00008.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–732. doi: 10.7326/0003-4819-152-11-201006010-00232.
    1. Hall MA, Camacho F, Lawlor JS, Depuy V, Sugarman J, Weinfurt K. Measuring trust in medical researchers. Med Care. 2006;44:1048–1053. doi: 10.1097/01.mlr.0000228023.37087.cb.
    1. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001;93:139–147.
    1. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25–30. doi: 10.1177/0272989X9501500105.
    1. Kaphingst KA, McBride CM, Wade C, Alford SH, Reid R, Larson E, Baxevanis AD, Brody LC. Patients’ understanding of and responses to multiplex genetic susceptibility test results. Genet Med. 2012;14:681–687. doi: 10.1038/gim.2012.22.
    1. Kaphingst KA, Facio FM, Cheng MR, Brooks S, Eidem H, Linn A, Biesecker BB, Biesecker LG. Effects of informed consent for individual genome sequencing on relevant knowledge. Clin Genet. 2012;82:408–415. doi: 10.1111/j.1399-0004.2012.01909.x.
    1. DeSalvo KB, Fan VS, McDonell MB, Fihn SD. Predicting mortality and healthcare utilization with a single question. Health Serv Res. 2005;40:1234–1246. doi: 10.1111/j.1475-6773.2005.00404.x.
    1. Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol. 2002;21:564–572.
    1. Carleton RN, Norton MA, Asmundson GJ. Fearing the unknown: a short version of the intolerance of uncertainty scale. J Anxiety Disord. 2007;21:105–117. doi: 10.1016/j.janxdis.2006.03.014.
    1. Prochaska JO. Decision making in the transtheoretical model of behavior change. Med Decis Making. 2008;28:845–849. doi: 10.1177/0272989X08327068.
    1. Zick CD, Mathews CJ, Roberts JS, Cook-Deegan R, Pokorski RJ, Green RC. Genetic testing for Alzheimer’s disease and its impact on insurance purchasing behavior. Health Aff (Millwood) 2005;24:483–490. doi: 10.1377/hlthaff.24.2.483.
    1. Nelson D, Kreps G, Hesse B, Croyle R, Willis G, Arora N, Rimer B, Vish Viswanath K, Weinstein N, Alden S. The health information national trends survey (HINTS): development, design, and dissemination. J Health Commun. 2004;9:443–460. doi: 10.1080/10810730490504233.
    1. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29:21–43.
    1. Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention. [ ]
    1. Roter D, Larson S. The Roter interaction analysis system (RIAS): utility and flexibility for analysis of medical interactions. Patient Educ Couns. 2002;46:243–251. doi: 10.1016/S0738-3991(02)00012-5.
    1. Brehaut JC, O’Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D. Validation of a decision regret scale. Med Decis Making. 2003;23:281–292. doi: 10.1177/0272989X03256005.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner